These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4346447)

  • 1. Areexamination of phase IV Bordetella pertussis.
    Aprile MA
    Can J Microbiol; 1972 Dec; 18(12):1793-801. PubMed ID: 4346447
    [No Abstract]   [Full Text] [Related]  

  • 2. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antigenic structure of B. pertussis and its relationships to the conditions of strain circulation. II. The serological polymorphism of B. pertussis strains isolated from sick children and experimentally].
    Kuznetsov EA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):103-7. PubMed ID: 4369488
    [No Abstract]   [Full Text] [Related]  

  • 4. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the genetics and physiology of Bordetella pertussis in the production of vaccine and the study of host-parasite relationships in pertussis.
    Parker C
    Adv Appl Microbiol; 1976; 20():27-42. PubMed ID: 187020
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines.
    Kamachi K; Fukuda T; Han HJ; Toyoizumi-Ajisaka H; Mochida K; Konda T; Horiuchi Y; Arakawa Y;
    Biologicals; 2010 Mar; 38(2):290-3. PubMed ID: 20064727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agglutination of Bordetella species by lectins.
    Corbel MJ; Abraham AM
    FEMS Microbiol Lett; 1992 Jan; 69(3):245-8. PubMed ID: 1555759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 9. Semicontinuous cultivation of Bordetella pertussis.
    Stránský V; Stejskal A; Stejskal V
    Prog Immunobiol Stand; 1967; 3():266-8. PubMed ID: 4314428
    [No Abstract]   [Full Text] [Related]  

  • 10. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].
    Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 12. The importance of agglutinin production in mice in the determination of the definitive serotype of Bordetella pertussis.
    Bronne-Shanbury CJ
    J Hyg (Lond); 1976 Apr; 76(2):257-64. PubMed ID: 177702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 14. [The development of a process for culturing Bordetella pertussis immobilized on a polyurethane carrier].
    Miriasova LV; Basnak'ian IA; Kopaeva TV; Sarkisov IIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):6-9. PubMed ID: 10851980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of culture methods on the biological activities of Bordetella pertussis].
    Hirayanagi F
    Nihon Saikingaku Zasshi; 1969 Jan; 24(1):8-14. PubMed ID: 4306072
    [No Abstract]   [Full Text] [Related]  

  • 16. The occurrence of Bordetella pertussis serotypes in Australia, 1950-1970.
    Blaskett AC; Gulasekharam J; Fulton LC
    Med J Aust; 1971 Apr; 1(15):781-4. PubMed ID: 4324689
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic structure and phase variation in Bordetella pertussis.
    Nakase Y; Takatsu K; Kasuga T
    Jpn J Microbiol; 1969 Sep; 13(3):283-91. PubMed ID: 4310290
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
    Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
    Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of HBP-2 and FGP-1 culture media in the production of Bordetella pertussis by fermentation].
    Medina García A; Martín Escobar TA; Reyes ET
    Salud Publica Mex; 1981; 23(6):575-84. PubMed ID: 6278656
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of glutamic acid to supplement fluid medium for cultivation of Bordetella pertussis.
    Lane AG
    Appl Microbiol; 1970 Mar; 19(3):512-20. PubMed ID: 4314842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.